|
AHSA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.796000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.056400E-02 |
| Normal-vs-Stage2 |
2.097800E-01 |
| Normal-vs-Stage3 |
2.375400E-03 |
| Normal-vs-Stage4 |
2.785700E-02 |
| Stage1-vs-Stage2 |
6.387600E-01 |
| Stage1-vs-Stage3 |
3.422700E-03 |
| Stage1-vs-Stage4 |
2.341600E-01 |
| Stage2-vs-Stage3 |
2.488100E-02 |
| Stage2-vs-Stage4 |
2.573600E-01 |
| Stage3-vs-Stage4 |
3.895200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.859920E-02 |
| Normal-vs-AfricanAmerican |
2.009800E-02 |
| Normal-vs-Asian |
8.438400E-01 |
| Caucasian-vs-AfricanAmerican |
4.112200E-01 |
| Caucasian-vs-Asian |
1.864110E-03 |
| AfricanAmerican-vs-Asian |
9.444500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.775990E-02 |
| Normal-vs-Female |
3.772300E-02 |
| Male-vs-Female |
3.900600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.175700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.392300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.061800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.825800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.892580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.166200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.629200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.870600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.973600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.963600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.803600E-03 |
| Classical-VS-Follicular |
1.036770E-01 |
| Classical-VS-Other |
6.914800E-01 |
| Classical-VS-Normal |
6.708200E-02 |
| Tall-VS-Follicular |
1.363990E-01 |
| Tall-VS-Other |
2.349800E-01 |
| Tall-VS-Normal |
7.015400E-04 |
| Follicular-VS-Other |
3.110600E-01 |
| Follicular-VS-Normal |
1.257970E-02 |
| Other-VS-Normal |
7.508600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.881900E-02 |
| Normal-vs-N1 |
1.312020E-02 |
| N0-vs-N1 |
3.234200E-01 |
|
|
